0000950170-22-025462.txt : 20221121 0000950170-22-025462.hdr.sgml : 20221121 20221118180336 ACCESSION NUMBER: 0000950170-22-025462 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20221116 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221121 DATE AS OF CHANGE: 20221118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GELESIS HOLDINGS, INC. CENTRAL INDEX KEY: 0001805087 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 844730610 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39362 FILM NUMBER: 221403073 BUSINESS ADDRESS: STREET 1: 501 BOYLSTON STREET, SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-327-7737 MAIL ADDRESS: STREET 1: 501 BOYLSTON STREET, SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. DATE OF NAME CHANGE: 20200227 8-K 1 gls-20221116.htm 8-K 8-K
0001805087false0001805087gls:PublicWarrantsMember2022-11-162022-11-1600018050872022-11-162022-11-160001805087us-gaap:CommonStockMember2022-11-162022-11-16

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 16, 2022

 

 

Gelesis Holdings, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39362

84-4730610

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

501 Boylston Street

Suite 6102

 

Boston, Massachusetts

 

02116

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 617 456-4718

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common stock, par value $0.0001 per share

 

GLS

 

New York Stock Exchange

Redeemable warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50

 

GLS WS

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On November 16, 2022, Gelesis Holdings, Inc. (the “Company”) received a notification letter (the “Notice”) from the New York Stock Exchange (the “NYSE”) advising that it was not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE Listed Company Manual because its total market capitalization was less than $50 million over a 30 trading-day period and its stockholders’ equity was less than $50 million over a separate 30 trading-day period. The Company’s common stock will continue to be listed and traded on the NYSE during the Cure Period referred to below, subject to the Company’s compliance with other NYSE continued listing standards.

In accordance with Section 802.02 of the NYSE Listed Company Manual (“Section 802.02”), the Company intends to contact the NYSE within 10 days of its receipt of the Notice to confirm receipt of the Notice and confirm that it intends to present to the NYSE a plan detailing actions the Company has taken, or will take, to bring it into conformity with continued listing standards within 18 months of receipt of the Notice (the “Cure Period”). Pursuant to Section 802.02, the Company has 45 days from receipt of the Notice to submit its plan. The Company intends to develop and submit such plan within the required timeframe. If the NYSE accepts the plan, the Company will be subject to quarterly monitoring by the NYSE for compliance with the plan.

The Company’s common stock will continue to trade under the symbol “GLS,” but will have an added designation of “.BC” to indicate that the Company is not currently in compliance with NYSE continued listing standards.

In the event that the Company fails to regain compliance with the NYSE continued listing standards, the Company’s common stock will be subject to NYSE’s suspension and delisting procedures.

Item 7.01 Regulation FD Disclosure

As required by Section 802.02, the Company issued a press release on November 18, 2022 announcing that it had received the Notice. A copy of the press release is furnished herewith as Exhibit 99.1.

The information furnished pursuant to this Item 7.01 and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.

 

Exhibit

Number

 

Description

99.1

 

Press Release dated November 18, 2022

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

Forward-Looking Statements

Certain statements, estimates, targets and projections in this Current Report on Form 8-K may constitute “forward-looking statements” within the meaning of the federal securities laws. The words “anticipate,” “believe,” continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that statement is not forward looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements include, but are not limited to, statements regarding the Company’s or its management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. the Company gives no assurance that any expectations set forth in this Current Report on Form 8-K will be achieved. Various risks and uncertainties (some of which are beyond the Company’s control) or other factors could cause actual future results, performance or events to differ materially from those described herein. Some of the factors that may impact future results and performance may include, without limitation: the Company’s ability to regain compliance with the continued listing standards of the NYSE within the applicable cure period, the Company’s ability to continue to comply with applicable listing standards of the NYSE, and other important factors discussed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and in other filings that the Company makes with the Securities and Exchange Commission. These filings address other important risks and uncertainties that could cause actual results and events to differ materially from those contained in the forward-looking statements.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

GELESIS HOLDINGS, INC.

 

 

 

 

Date:

November 18, 2022

By:

/s/ Elliot Maltz

 

 

 

Elliot Maltz
Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 EX-99.1 2 gls-ex99_1.htm EX-99.1 EX-99.1

 

img249351287_0.jpg 

Exhibit 99.1

 

Gelesis Receives Notice of NYSE Market Capitalization Listing Rule Non-Compliance

The Company Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard

BOSTON, November 18, 2022 - Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis” or the “Company”) today noted that on November 16, 2022, the Company received a notification letter (the “Notice”) from the New York Stock Exchange (the “NYSE”) advising that it was not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE Listed Company Manual because its total market capitalization was less than $50 million over a 30 trading-day period and its stockholders’ equity was less than $50 million over a separate 30 trading-day period. The Company’s common stock will continue to be listed and traded on the NYSE during the Cure Period referred to below, subject to the Company’s compliance with other NYSE continued listing standards.

In accordance with Section 802.02 of the NYSE Listed Company Manual (“Section 802.02”), the Company intends to contact the NYSE within 10 days of its receipt of the Notice to confirm receipt of the Notice and confirm that it intends to present to the NYSE a plan detailing actions the Company has taken, or will take, to bring it into conformity with continued listing standards within 18 months of receipt of the Notice (the “Cure Period”). Pursuant to Section 802.02, the Company has 45 days from receipt of the Notice to submit its plan. The Company intends to develop and submit such its plan within the required timeframe. If the NYSE accepts the plan, the Company will be subject to quarterly monitoring by the NYSE for compliance with the plan.

The Company’s common stock will continue to trade under the symbol “GLS,” but will have an added designation of “.BC” to indicate that the Company is not currently in compliance with NYSE continued listing standards.

About Gelesis

Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis”) is a consumer-centered biotherapeutics company.

Forward-Looking Statements

Certain statements, estimates, targets and projections in this press release may constitute “forward-looking statements” within the meaning of the federal securities laws. The words “anticipate,” “believe,” continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that statement is not forward looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements include, but are not limited to, statements regarding Gelesis’ or its management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts, or other characterizations of future events

 

 

 

or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Gelesis assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Gelesis gives no assurance that any expectations set forth in this press release will be achieved. Various risks and uncertainties (some of which are beyond Gelesis’ control) or other factors could cause actual future results, performance or events to differ materially from those described herein. Some of the factors that may impact future results and performance include, without limitation: Gelesis’ ability to regain compliance with the continued listing standards of the NYSE within the applicable cure period, Gelesis’ ability to continue to comply with applicable listing standards of the NYSE, and other important factors discussed in the “Risk Factors” section of Gelesis’ most recent Annual Report on Form 10-K and in other filings that Gelesis makes with the Securities and Exchange Commission. These filings address other important risks and uncertainties that could cause actual results and events to differ materially from those contained in the forward-looking statements.

Contact:

Investors: ir@gelesis.com
Media: pr@gelesis.com

 

Source: Gelesis Holdings, Inc.

 

 

 GRAPHIC 3 img249351287_0.jpg GRAPHIC begin 644 img249351287_0.jpg M_]C_X 02D9)1@ ! @ 0 ! #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/U?5$TNT\P@-*QQ&GJ?7Z5 MPUWJ-W?.6GF9@?X*IFDU?RR3MC0 #Z\_UK#KX[-<94JUI4T_=6EC MZ' 8>$*:FUJR6"YFMG#PRO&P[J<5V&@:Z=0_T:YP+@#*L.-X_P :XJK.GS-! MJ-O*G59%_GS7/@,94P]56?N]4;8K#PK0=UJ>E4445]R?,!1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !16 M'J?B6WL9##"OGRCAL'"J?K64/%]YOR;> KZ#.?SS7GUOT/>M6NNE6IUH\]-W1SU*5U9575HJZ>Z/:P6.@H*G4=K'+UI:'9->ZK" ,I&P=SVP/ M\:T(/"%TSCSYXD3OLRQ_I73V&GV^G6_E0+@'EF/5C[UC@"%%%% !1145Q1:VR[1T:4\G\!_C26WC"3>!=6RE>YB."/P->;_:^$YN7F_!V.S^S\1:]C MK**AM;J&\@6:!PZ-W]/:IJ]*,E)73NCC::=F%%%%,04444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 5F:]>M8Z5(\9Q(Y"(?0G_ZV:TZPO%D32:0KKG$ M*19$8JZG(([&O1] M.NOMNGP7'=UY^O0_K7FU>@Z!$T.AVJL,$J6_ DD?SKWLAG+VLH]+?C<\K-8K MV<9=;FE1117U)X84444 %4[S5+*P(%Q.JL>BCD_D*??W7V.PGN,9**2![]OU MKSB662>5I96+.QR6/>O)S/,7A+1@KR9WX+!^WO*3T1WUKKNG7<@CCG"N>BN" MN:TJ\LKNO#5\]YINV4EGA;9N/<8XK++C$,#Z@BO&SRA['^GXUW%>>Z%$TVM M6H7^%]Q^@YKT*OKR>AX&:1BJR:ZH****]H\T**** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH *9-"EQ"\,J[D<884^BDTFK,:=G=' ZIH5UI\ MC,J-+;]I%&<#W]*R@,G ZUZG30BAMP49]<5X-7(82E>G.R[6O^IZM/-9*-IQ MNSB](\.SW6Y;T$@S5FO+*ZGPMJ MLKRFPF MW7[SIA?KU%><.C1NR.I5E."".0:]1K/OM%LM0;?-&1)_?0X)_P :\C-,NEBK M3@_>1Z&"QBH7C+9GGE=QX7LWM=,,D@(:9MX!_NXXJ2U\-Z=:R!]CRL.GFG(' MX#BM>LLLRN>'G[6J]>B1IC<=&K'DAL%%%%>X>6%1S7$-NH:::.,'H78#^=0Z MC>"PL)KDC)0<#U)X'ZUYW<7,UW,TT\A=VZDUY>89E'"6BE>3.["8-XB\F[)' MI,-U;W(/D3QRXZ[&!Q6;KNC#4X5>(A;B,?*3T8>AKAH9I+>59879'4Y#*:]" MTB__ +1TZ.=@ _W7 ]16.%QM/,8RH58V9I7PT\&U5@S@+BUGM)#'/$\;>C"D M@MI[J01P1/(Q[*,UZ:0&&" 1[T!0HP /:N?_5^/-\>GIK^?Z&O]K.WPZ^IC MZ#HO]F1M+-@W+C!Q_"/2MFBBO=H4(4*:IP6B/,JU959.D6VJ(/-!61>%D7J/;W%>;FF"EBJ24-T=N"Q*H3;ELSSRMOPM M;O+K"R@';"I+'ZC 'Z_I5]?!P\SYKTE/:/!_G706-C;Z?;B&W3"]23U8^IKR M,!E->-95*JLEK_5COQ6/I.FXTW=LLT5BW/BBPMYC&OF38."T8&/S)YK1L;^W MU"'S;=]P'!!X*GW%?0T\51J3<(239Y$Z%2$>:4;(LUC:QK\>F.((X_-GQD@G M 7ZULUP7B."2+6IF<'$F&4^HQ7)FN)JX>AS4]V[7['1@:,*M6TS8T[Q4)[A8 M;N)8]YP'4\ ^XKI:\PAADN)TAB4L[G KTY00H!.2!UK')\76Q$)*KK:VIIF M-"G2DN32XM%%8EQXIT^"8QJ)9<'!9 ,?AD\UZ=;$4J*O4E8XJ=*=1V@KEG7X M'N-%N$C&6 #8]<')_2O/J]*LKZWU"#S;=]R]".A!]"*R;_PK;7,IEMY#;LW) M7;E<^P[5X^:8"6+<:]!WT_JQZ."Q4:%Z=70XNNZ\,6[P:.I<$>:YD /IP!_* MJUGX3MX9!)PJK'XKTYW"LL\8_O,@Q^A-G48K5NO"ME/,9(WDA#')5<$? MAZ5I:?IMMIL)CMU.6Y9F.2U?-X+*:]+$*<[67XGL8G'TJE%QCNRY4%S9V]Y' MLN(5D4=-PZ?0]JGHKZ645)6DKH\9-IW14M-+LK%BUM;JC'C=DD_F:MT44H0C M!0Y2E)WD[LHZR9!H]V8L[O+/3T[_IFO.J]3(!&",@U@W'A2RFF,D
C@,73HIQF9O@\R?;K@#/E^5\WUR,?UKL*J MV&GV^G0>5;J0"0=4C&2/Z55B\5Z=(X5A/&/[SH,?H37++&X>$N24U?U M-XX:M)@5Y97J M$(801A_O!1GZXKZ?(:TI0G3>RM;YGB9K3BI1FMV<[K^OR6LQM+0A9 /GDQG' ML*YT:MJ"ON%[<9SGF0D?E1JP9=7O V<^B['H MX?#TX4TDCMM UQM1#6]QC[0HR&'&\?XUND@#). *X'PXKG7;?9VW$_3::[/5 M%D?2KI8LES$V ._%?199BJE7"N<]7&_SLKGCXVA"%=1CHG^!DW/BVUBF*0PO M,HXWYV@_2M33=4M]3A+P$AEX9&ZK7G-=!X160ZE*RY\L188]LY&/ZUY^!S7$ M5<2H3U3\MCKQ. I4Z+E'='9T445],>*%%%% !1110 4444 (2%4LQ Y)/:N M>N/%UK'*5A@>51_'G;GZ5J:RLCZ/=+%G<8ST]._Z9KSJO#S;'UL/*,*6E];G MIX#"TZT7*>IZ/IVI6^IP&6 G*G#*W534UU*Z:&-J3P3KM>\D_P,:N&C'$JDGHVC MFKWQ!?W(+^TE#-,\Z9^9)6SG\>HK+HKY3ZY7Y_:< M[OZGO?5Z7+R\JL>G6MQ'=VT=Q$]=]7EG4UZB@(10W7 S7U&0 MUI2A.F]E:WSN>)FM.*E&:W8ZBBBO?/)"BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R]=TLZG9 M1X\^,[DSW]16I16=:E&M!TY[,NG4E3DIQW1Y=)&\4C)(I5U."I&"*;7I-UIU MG>_\?%NCG^]T/YCFJT7A_2XGW+:*3_M,6'Y$U\U/(:O-[LE;YGLQS6G;WHNY MS/A_2)+VZ2XE0BVC.[)'WR.PKN:15"J%4 < #M2U[N"P<,)3Y(ZM[L\O$XF M5>?,]C"US0/[1?[1;LJ7&,,#T?\ ^O7/+X]C6CCZU*/(M5YF3HNBII<;.[![AQAF'0#T%:U%%=U&C"C!4Z:LDG7,QE*/&SI[DGW-6**F&&HTY. M<(I,J5:I*/+*3:"BBBMS(**** "BBB@ HHHH *QY_#6FSS&38\9)R0C8'Y5L M45E5H4ZRM4BF7"K.F[P=B"TLX+& 0V\81.ON3ZFI)H8[B%X95W(XPP]J?15J M$5'D2T["5_8N%Y^;6W:^G^?XG=_:5?EY=/49#"D$*11*%1!A0/2LS7]+.I60,8_?Q9 M*>_J*UJ*]*K0A5INE):,XZ=64)J:W/+G1XW9'4JRG!4C!%-KTFZTZSO?^/BW M1S_>Z'\QS5>+P_I<3[EM%)_VF+#\B:^;GD-;F]V2M\SV(YK3M[T7U=O2 !0 H Z 4M>[@L'#"4^2.KZL\O$XB5>?,PHH MHKL.<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBN8UWQ[H6A,\4EP;FY4X,%O\Q!]ST'YY]J .GHKQK4OBYJUP M2MA:6]HG9GS(_P"? _2NH'G/S7#-_,T^47,?1]%>!6WQ&\46Q' M_$R\U1_#+$C?KC/ZUTVE_%^4,J:MIJ,O>2U."/\ @+'G\Q2LQW/5Z*R]&\1: M5K\/F:==I*0,M'T=?JIY_I6I2&%%%% !1110 45YAXY\$0")& M >,,:QM+^)?B*[U:RMI9;)O^>MM_P!^11_PM+Q-_P ];;_OR*=A7/N#O\ XD^)KYCMO5M4 M/\%O&!C\3D_K3L*Y[U17S((VW+K>HD_[5R[ M#\B:?*+F/I"BO!;+XE>)[,C=>I/.C M)=/Q'4?K2L.YZ-14-K=6][;I<6L\??$/Q=J MOAN_LH=/>)4EB+-OCW<@XH ]!HKPS_A:7B;_ )ZVW_?D5[G3:L).X4444AA1 M110 445B^(/%6E>&X ]_/^]892",9=_P[#W.!0!M45XSJOQ:U:Y9ETVWALX^ MS,/,?]>/TKFKCQEXDNF+2:U>*3_SSD,8_P#'<4["N?1=%?-O_"3Z_P#]!S4_ M_ N3_&K=MXX\36A!CUBX;'_/4B3_ -"!I\HN8^AZ*\>TKXN:C"RIJEG#X/Z5Z-H7BW1_$2#[#=#S\9:WD^60?AW^HS2L.YMT444AA117(>)_B! MI_A^:)K7Q*U$>=;:-#!&>BNJH?R=LTB M_$#Q#H-PD?B?0RL+' FA7:?PY*M] 13L*YZ915/2]5LM9L4O+"=9H7[CJ#Z$ M=C5RD,*@O+RVT^TDNKN9(8(QEW(]1-M;. M1IMNQ$8'_+5O[Y_I[?6FE<3=BUXM^(]]K+R6FF,]I8="P.))1[GL/8?C7"TJ MJ68*H)8G ')->N>#/AK#;Q1ZCKL0DN&&Z.T8?+'[OZGVZ#W[5L3N>>:/X3U MO70'L+&1H2?]<_R)^9Z_AFNOM/@]J#J#>:I;0GN(HVDQ^>VO754(H50 H& M. *6IN58\P'P<@P,ZU(3WQ;C_P"*J*;X-\9@UOGT>V_J&_I7JE%%V%D>(WWP MI\06JEK9K6[ Z+')M;\F 'ZUR.H:7?Z5/Y-_:36\G82*1GZ'O^%?3E07=E:W M]NUO>6\4\+=4D4,/UHN%CSCX2Z 8K>XUR=/FES#;Y'\(/S-^)&/P->G5!9V= MOI]G%:6L0B@B7:B#L*GI,:"BBB@ HHHH \,^*7_(ZR?]<(_Y5RFG6;:CJ=I8 MHX1KF9(0QZ LP&?UKJ_BE_R.LG_7"/\ E6!X8_Y&S1O^OZ#_ -#%6MB'N=I_ MPI[4/^@K;?\ ?MJ/^%/:A_T%;;_OVU>O45-V59'D/_"GM0_Z"MM_W[:C_A3V MH?\ 05MO^_;5Z]11=A9'D/\ PI[4/^@K;?\ ?MJ]!\(Z#+X;T%=/FG29Q(S[ MT! Y^M;M%%PL%%%%(84444 >&?%+_D=9/^N$?\JYO0O^1ATW_KZB_P#0Q72? M%+_D=9/^N$?\JYO0O^1ATW_KZB_]#%6MB.I]+T445!84444 %%%% !1110 5 MY9\9?^8)_P!M_P#VG7J=>6?&7_F"?]M__:=-;B>QY77HEM\)+^XM8IQJEL!( M@< HW&1FO.Z^G=,_Y!-G_P!<$_\ 013;$D>5_P#"GM0_Z"MM_P!^VH_X4]J' M_05MO^_;5Z]12NQV1Y#_ ,*>U#_H*VW_ '[:C_A3VH?]!6V_[]M7KU%%V%D< MAX&\'7'A/[?Y]U%/]I\O&Q2-NW=Z_P"]77T44AA1110 5X[\2/&4MY>2Z'82 M%;2%MMPZG_6N.J_0=/'8-5U2?4;N,20V6WRT M89#2'.#^&/S(KVBAL21Y9%\&_ES-K?S8Z);< _4MS4%Q\';I5_T;6(9#Z20E M/Y$UZU12NQV1X%JGP[\1Z6C2&S%U$O5[5M__ ([PWZ5RQ!5BK @@X(/:OJ:L M;4_"NBZO>PWEW8QM<1.KB11@MCLW]X?6G<7*9'PZ\.OH7AX2W 875X1*ZG^! MN.3]<=J["BBI*"BBB@ KR'XP_\ (6TW_K@W_H5>O5Y#\8?^0MIO_7!O M_0J:W$]CS:OJ>OEBOJ>G(40HHHJ2@HHHH Y_QCXFC\,:*UR KW4IV6\9[MZG MV'7\AWKY_O;VYU&\EN[N9IIY6W.['D_Y]*[+XJZB]UXM^R9/EV<*J%_VF&XG M\BOY5QEG:R7U];VD6/,GD6),^K' _G5(EEO2-"U+7;GR-.M7F8?>8<*@]R>! M7OI$!O-5@@8C[L49DQ^96O3=%T:TT'2X;"SC"H@^9L_P!=U9%[\)M>MU+6LUI= =%5RC'_ +Z&/UKVJBB["R/F M34=)U#2)_(U"TEMY.PD7 ;Z'H?PKH_AWX=?6_$4=PX86ED1+(PXRV?E7/N>? MH#7N%[8VFHVS6U[;Q3PMU2101_\ KJMHNAV&@6;6FG0^7$TAD.3DDGW/H,#\ M*=Q6-&BBBI*.;\<>(&\.^&IKB$XNIB(8#Z,<_-^ !/UQ6+X"\*Q:9I8UZ_C\ M[4KA#,IDY,:GD=?XCU)Z\X]9^"O$UWX8M-5N(-*>\B?RO,E#E5AQN W<'K MGVZ5UOPNTJ6:XO\ Q+/+$6NB\:QQGH2VYLCMR!@>E-H290LUF^'GC^.Q$KMI M&H$ ;CP 3@$^ZGJ?3ZUZU7F7QA5!9Z3)TE660*>^,#/\A7;?:-3_ +C?]\4F M-'-_%'Q =,T)=-@J]A90Z;I]O96Z[88(Q&H]@/YU8J64@HHHI#"BBB@ HHHH **** " MBBB@ HHHH \,^*7_ ".LG_7"/^58'AC_ )&S1O\ K^@_]#%;_P 4O^1UD_ZX M1_RK \,?\C9HW_7]!_Z&*OH1U/I*BBBH+"BBB@ HHHH **** "BBB@#PSXI? M\CK)_P!<(_Y5S>A?\C#IO_7U%_Z&*Z3XI?\ (ZR?]<(_Y5S>A?\ (PZ;_P!? M47_H8JUL1U/I>BBBH+"BBB@ HHHH **** "O+/C+_P P3_MO_P"TZ]3KRSXR M_P#,$_[;_P#M.FMQ/8\KKZ=TS_D$V?\ UP3_ -!%?,5?3NF?\@FS_P"N"?\ MH(IR%$M4445)04444 %%%% !1110!A^,HGF\&ZLB#+?9F;'L.3^@KYTKZEDC M26-HW4,C JRGH0:^=O%?AV?PUKK5\NVMU/97,=S;2M%-&VY'0X(->O^%?B?:7ZI M::V4M;KH)^D0_&'_D+:;_UP;_T*FMQ/8\VKZGKY8KZGIR% M$****DH**** / _B3"T7CO4"V<2"-U)[C8H_F#6!I-XNGZS8WK*66WN(Y2!W M"L#_ $KU?XI>&9-0LH]8M(R\UJI695'+1]<_@<_@3Z5XY5K8A[GU'!/%RZ/KNFZ] M:BXTZZ29?XEZ,A]&'45+129HT444AA1110 4444 3Q@/]#_ #S775P.O?#^;^TC MK'AF[^P7V2S1Y*HQ/4@CIGTZ'VIB)?!'@FZ\/VVJV^K-:7$-\J)LB9F! W@@ MY4?WA3/#/@_6?"NO7$EM>6LFCS,=\/L^HF'2=/;[Z+P6'I@$L?H2!0!5U.?\ X3[X MA6EG:?O-,T\Y>0?=8 @N1]2 H^F:]7K(\.^'+#PUI_V6R0EFP996^](?4_T' M:M>A@CYCU.LBCZ[&JNA*/>Z***@L**** "BBB@ HHK$G\8> M'K6XEMY]6MTEB<@L$0G.!UK6H * M*** "BBB@#PSXI?\CK)_UPC_ )5RNFWAT[5+.^"!S;3I,$)QNVL#C/X5U7Q2 M_P"1UD_ZX1_RKD;2UEO;R"T@4--/(L<8)QEF.!S]35K8A[GI'_"X[C_H"Q?^ M!!_^)H_X7'IO\ _"X[C_H"Q?\ @0?_ (FC_A<=Q_T!8O\ P(/_ ,36!_PK+Q3_ M ,^47_?]/\:/^%9>*?\ GRB_[_I_C1H&IZOX-\2OXITB6^>U6W,Z:0!7#?*50=1[@UUM2RD%%%% !1110! MX9\4O^1UD_ZX1_RKF]"_Y&'3?^OJ+_T,5TGQ2_Y'63_KA'_*N;T+_D8=-_Z^ MHO\ T,5:V(ZGTO1114%A1110 4444 %%%% !7EGQE_Y@G_;?_P!IUZG7EGQE M_P"8)_VW_P#:=-;B>QY77I-M\79[:UA@&CQL(T5,^>><#']VO-JZR+X;^)IX M4ECLHRCJ&4^>G0\^M4R4=%_PN.X_Z L7_@0?_B:/^%QW'_0%B_\ @__ !-8 M'_"LO%/_ #Y1?]_T_P :/^%9>*?^?*+_ +_I_C2T'J;_ /PN.X_Z L7_ ($' M_P")KI_!?CB3Q7>74#V*6P@C#@K(6SDX]!7G/_"LO%/_ #Y1?]_T_P :[3X< M^%-7\/:A>RZE;I$DL2JA616R0<]C0[ KGHE%%%24%%%% !69KV@V/B+37LKZ M/*GE)%^]&WJ#6G10!\]^)O!FJ>&9BTT9GLR?DN8Q\I]F_NGZ_AFNA%<%XA^%NG:AOGTEQ8W!Y\L\Q-^'5?PX]JI,EH\W\/^,M8\ M.LJ6MQYEL#DV\OS(?I_=_"O5O#_Q(T;6BD-PWV"[;CRYF^1C_LOT_/%>/:UX M;U;P_-LU"T>-2<+*/F1OHPX_#K653M<5['U/17@7AGQ[JWAUDA+F[L1P;>5O MNC_9;^'^7M7L^@>(].\1V7VFPER1_K(FX>,^A']>E2T4GO5Y#\8?^0MIO_7!O_0J:W$]CS:OJ>OEBOJ>G(40HHHJ M2@HHHH ",C!Z5Y;XQ^&1=Y-0T"-1GYI+/I^*?X?EZ5ZE10F%CY;EBD@E:*:- MHY$.&1Q@@^A!J6SOKK3KE;FSN)()EZ/&V#_^JOH37O">D>(HS]NMAYV,+/'\ MLB_CW^AS7E7B#X9:QI.Z:Q']H6PY_=KB11[KW_#/X5:9#1L^'OBRZ!+?7H-X MZ?:H!@_5EZ?B/RKTS3M4L=6M5N;"ZCN(3_$AZ>Q'4'V-?,A!5BK @@X(/:K> MFZI?:1=K=6%S);S#NAZ^Q'0CV-)H:9]-T5Y_X2^)=MJK1V6KA+6\;"I*.(Y# M_P"RG]/Y5Z!4E!1110 4444 %%%% !1110!\Y^,+$Z=XOU2W(P//:11_LM\P M_0U3T34#I6N65_SB"978#NH/(_+->@_%S166>TUJ)/E<>1,1V(Y4_B,C\!7E M]6B&?4J.LL:R(P9& 96'0@]Z=7!?#'Q*NIZ,-)N)/]+LUP@)Y>+M^73\J[VH M+"BBB@ HHHH *^;?$_\ R-FL_P#7]/\ ^AFOI*OFWQ/_ ,C9K/\ U_3_ /H9 MJHDR-_X6_P#(ZQ_]<)/Y5[G7AGPM_P"1UC_ZX2?RKW.DQH****0PHHHH \,^ M*7_(ZR?]<(_Y5@>&/^1LT;_K^@_]#%;_ ,4O^1UD_P"N$?\ *L#PQ_R-FC?] M?T'_ *&*OH1U/I*BBBH+"BBB@ HHHH **** "BBB@#PSXI?\CK)_UPC_ )5S M>A?\C#IO_7U%_P"ABND^*7_(ZR?]<(_Y5S>A?\C#IO\ U]1?^ABK6Q'4^EZ* M**@L**** "BBB@ HHHH *\L^,O\ S!/^V_\ [3KU.O+/C+_S!/\ MO\ ^TZ: MW$]CRNOIW3/^039_]<$_]!%?,5?3NF?\@FS_ .N"?^@BG(42U1114E!1110 M4444 %%%% !1110 4444 ,FABN(6AFC26)QAD=0P8>X->>^)?A997BOM7>@:M#J%H MV'0_,F>)%[J?8_\ UZ]3^*^A0W&BIK*)BYM65'8#[T;'&#]"1CZFO&ZM:D/0 M^GM/OH-3TZWOK9MT,Z!U/U['W[59KA?A1>-<>$7@O5Y#\8?^0MIO_7!O_0J:W$]CS:OJ>OEBOJ> MG(40HHHJ2@HHHH **** "BBB@#G]?\&:+XA#/=6PCN3TN(?E?\>Q_'->/>*_ M!6H>%Y?,<_:+%SA+A!C!]&'8U] U7OK*WU&RFL[J,203*5=3W'^--,31\P5[ M/\,/%$FJ6$FDWDF^YM%#1,>KQ=.?]TX'T(KR35[!M*UB\L&.XV\S1[O[P!X/ MXBMGP!>-9^-M-8' DQ'N#@_A7SIK.D76AZK/I]XFV6)N#V=>S#V-?3%)[0 ,L-^B_O;O"=3TN\T>^DLKZ!H9D/(/0CU![CW MJO!/-;3I/!*\4J'*NC8*GV-4U[OQ3H-B#]HU>S4CJHE M#-^0R:^?]=N8KSQ#J=U;OOAFNY9(VP1N4N2#@^QJD2SI/A;_ ,CK'_UPD_E7 MN=>&?"W_ )'6/_KA)_*O0W*H<,8G# &@" MW1110 5Y9\9?^8)_VW_]IUZG7EGQE_Y@G_;?_P!ITUN)['E=?3NF?\@FS_ZX M)_Z"*^8J^A-/\6>'X],M4?6;)66% 09AD' IL2.CHK%_X2_P[_T&K'_O\*/^ M$O\ #O\ T&K'_O\ "I*-JBL7_A+_ [_ -!JQ_[_ H_X2_P[_T&K'_O\* - MJBLVR\0:/J-P+>RU*UN)B"0D<@)P/:M*@ HHHH *9'+'+N\N17VL5;:<'NQ]A_/%>)Z3XCU71+YKNRO)%DD;=(&.Y9# M_M ]?KUII";/I*BO.]%^+.G7*K'J]N]G+T,D8+QGWQ]X?3GZUU]IXET.^4&V MU:S?/\/G -^1YI6'US"%]3(,5B:KXY\/:3&QDU&*>0=(K8B1C M[<<#\2* *'Q/NX[?P1X8,?T4UX370>+/%=WXIU!995\JVBR( M8 <[<]23W)K%M+6>^NXK6VC,DTKA$0=R:M:$/4]C^$ENT7A6XF8$>==,5]P% M4?SS7?5FZ!I*:'H5GIJ$'R(P&8?Q,>6/XDFM*H9:"BBB@ KR'XP_\A;3?^N# M?^A5Z]7D/QA_Y"VF_P#7!O\ T*FMQ/8\VKZGKY8KZGIR%$****DH***;)(D4 M;22,$1 69F. .I- "-+&CHKR*K.<("<%CUX]:?7S_XT\5R^(M>\^WD=+2V. MVV .#[O[$D?D!6UX=^*=_IZ+;ZO&;Z$<"4'$JCW[-^.#[T["N>S45S6G>/O# M>I*-NI1P.>J7/[LC\3Q^1K6\@]4E4_UI#+-%9]WKNDV"%KK4[2 M(#LTRY_ 9R:\[\7_ !.AGM)=/T$N3("KW9!7 [A ><^YQCMZAV%X;:?4 XS^.*M>!K=KKQMI2*/NS>8?HH+?TKGJ]4^$OA]U:?79T( M4J8;?(Z\_,P_+'YU3V)6YZG1114%A1110 4444 %%%% !1110!EZWX?TWQ#: M?9]0MPX'W)!PZ'U4]OY5Y/K_ ,+]7TUGETW_ (F%L.0%XE4>Z]_P_*O;**:8 MFCY*1>&1U*D?4&HZ^G;W3;'4H_+OK."Y4=!+&&Q],]*X?Q-X* M\/6L2RP::L;L>=LK@?ENQ3N*QXU16_\ V;:?\\O_ !X_XUJ:+H6FWVWC M>H^^PX)]C3%8XRGQ1232".*-I';HJ#)/X5[UIO@3PQ';QRC28FF?^ M D?^%','*?-M>J?!K_F-_P#;#_VI7??\(QH'_0#TS_P$C_PJW9:9I^F[_L-C M;6OF8W^1$J;L=,X'/4_G0V"1:HHHJ2@HHHH \,^*7_(ZR?\ 7"/^5<77TS=: M)I5].9[S3+*XE(QYDUNKMCZD5!_PC&@?] /3/_ 2/_"JN38^;:*^DO\ A&- M_P"@'IG_ ("1_P"%'_",:!_T ],_\!(_\*.8.4^;:*^DO^$8T#_H!Z9_X"1_ MX4?\(QH'_0#TS_P$C_PHY@Y3YMKU[X/?\@G4O^NZ_P#H-=I_PC&@?] /3/\ MP$C_ ,*N6>G6.G(R6-G;VJN=GGQ*^W/7&1QT'Y4T)GS%17TE_PC&@?] /3/\ MP$C_ ,*/^$8T#_H!Z9_X"1_X4^87*?-M%?27_",:!_T ],_\!(_\*/\ A&- M_P"@'IG_ ("1_P"%','*?-M%?27_ C&@?\ 0#TS_P !(_\ "C_A&- _Z >F M?^ D?^%','*>0_"W_D=8_P#KA)_*OSTRRMY0,>9#;JC8^H%7 MJ3=QI!1112&8GB+PKIGB:W"7L1$R#$<\?#I_B/8UY!X@^'FM:&6DCB-]:#I+ M I) _P!I>H_4>]>]44TQ-'RP1@X/6BOI34?#NC:L2U]IMM,YZN4 ;_OHY]33N)H\ZHKH8],LVD4&'@D#[Q_QKTWPUX*\.R6 M:W,NEQR2YQF1V8?D3C]*=Q6/(-*T74=;N1!IUI).^>2H^5?H7_'_ ">M@MX;6%8;>&.&)>B1J% _ 5)4ME)!1112 M&%%%% !7D/QA_P"0MIO_ %P;_P!"KUZJ=YI.FZBZO?:?:W3(,*9X5<@>V130 MF?,E?4]97_",:!_T ],_\!(_\*U:&[@E8****0PIDT,5Q!)!-&LD4BE71AD, M#U!%/HH \M\2_"G)>ZT!P.YM)6_]!8_R/YUYI?Z=>Z7<&WOK66WE'\,BD9^G MJ/<5].U#0F&Z@BGB/5)4#*?P-.XK'R]17M_B/P3XA]Z]3TWP_I&DTLP<^2>)9/;'\(^O/\Z]D@@BM;>.W@C6.&-0B(HP% Z 5)12;N-*P4444 0AA1110 4444 %%%% '__V0$! end EX-101.SCH 4 gls-20221116.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 gls-20221116_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Securities Act File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications Document Information [Table] Document Information [Line Items] Common Stock [Member] Class of Stock [Axis] Class of Stock [Domain] Public Warrants. Public Warrants [Member] EX-101.PRE 6 gls-20221116_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.DEF 7 gls-20221116_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information
Nov. 16, 2022
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 16, 2022
Entity Registrant Name Gelesis Holdings, Inc.
Entity Central Index Key 0001805087
Entity Emerging Growth Company true
Securities Act File Number 001-39362
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 84-4730610
Entity Address, Address Line One 501 Boylston Street
Entity Address, Address Line Two Suite 6102
Entity Address, City or Town Boston
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02116
City Area Code 617
Local Phone Number 456-4718
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period false
Common Stock [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common stock, par value $0.0001 per share
Trading Symbol GLS
Security Exchange Name NYSE
Public Warrants [Member]  
Document Information [Line Items]  
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
Trading Symbol GLS WS
Security Exchange Name NYSE
XML 9 gls-20221116_htm.xml IDEA: XBRL DOCUMENT 0001805087 gls:PublicWarrantsMember 2022-11-16 2022-11-16 0001805087 2022-11-16 2022-11-16 0001805087 us-gaap:CommonStockMember 2022-11-16 2022-11-16 0001805087 false 8-K 2022-11-16 Gelesis Holdings, Inc. DE 001-39362 84-4730610 501 Boylston Street Suite 6102 Boston MA 02116 617 456-4718 false false false false Common stock, par value $0.0001 per share GLS NYSE Redeemable warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 GLS WS NYSE true false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 3 24 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports gls-20221116.htm gls-20221116.xsd gls-20221116_def.xml gls-20221116_lab.xml gls-20221116_pre.xml gls-ex99_1.htm http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "gls-20221116.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "gls-20221116_def.xml" ] }, "inline": { "local": [ "gls-20221116.htm" ] }, "labelLink": { "local": [ "gls-20221116_lab.xml" ] }, "presentationLink": { "local": [ "gls-20221116_pre.xml" ] }, "schema": { "local": [ "gls-20221116.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 31, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 1, "memberStandard": 1, "nsprefix": "gls", "nsuri": "http://ir.gelesis.com/20221116", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "gls-20221116.htm", "contextRef": "C_b36dfdf8-4c91-4033-869d-2effa50cb139", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "role": "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "gls-20221116.htm", "contextRef": "C_b36dfdf8-4c91-4033-869d-2effa50cb139", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "gls_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Warrants.", "label": "Public Warrants [Member]" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://ir.gelesis.com/20221116", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ir.gelesis.com/20221116/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 16 0000950170-22-025462-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-22-025462-xbrl.zip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end